Sanofi, GlaxoSmithKline hit with a major delay on Covid-19 vaccine program as their first jab flops in older adults
Hours after Pfizer and BioNTech won the backing of an FDA panel for their mRNA vaccine, Sanofi and GSK announced that their closely watched program …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
